Strategies to improve drug development for sepsis

@article{Fink2014StrategiesTI,
  title={Strategies to improve drug development for sepsis},
  author={M. P. Fink and H. S. Warren},
  journal={Nature Reviews Drug Discovery},
  year={2014},
  volume={13},
  pages={741-758}
}
  • M. P. Fink, H. S. Warren
  • Published 2014
  • Medicine
  • Nature Reviews Drug Discovery
  • Sepsis, a common and potentially fatal systemic illness, is triggered by microbial infection and often leads to impaired function of the lungs, kidneys or other vital organs. Since the early 1980s, a large number of therapeutic agents for the treatment of sepsis have been evaluated in randomized controlled clinical trials. With few exceptions, the results from these trials have been disappointing, and no specific therapeutic agent is currently approved for the treatment of sepsis. To improve… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    Explore Further: Topics Discussed in This Paper

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 225 REFERENCES
    Animal models of sepsis
    • 230
    Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View
    • 365
    • Highly Influential
    • PDF